Immunogenomics and Metabolic Diseases Laboratory, Instituto Nacional de Medicina Genómica, SS, CDMX, Mexico; Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico.
Immunogenomics and Metabolic Diseases Laboratory, Instituto Nacional de Medicina Genómica, SS, CDMX, Mexico.
Gene. 2018 Dec 30;679:160-171. doi: 10.1016/j.gene.2018.08.076. Epub 2018 Aug 31.
Amerindian ancestry appears to be a risk factor for metabolic diseases (MetD), making Mexicans an ideal population to better understand the genetic architecture of metabolic health. In this study, we determine the association of genetic variants previously reported with metabolic entities, in two Mexican populations, including the largest sample of Amerindians reported to date. We investigated the association of eigth single-nucleotide polymorphisms (SNPs) in AKT1, GCKR, and SOCS3 genes with different metabolic traits in 1923 Mexican Amerindians (MAs) belonging to 57 ethnic groups, and 855 Mestizos (MEZs). The allele frequency of 7/8 SNPs showed significant differences between MAs and MEZs. Interestingly, some alleles were monomorphic in particular ethnic groups, and highly frequent in other ones. With the exception of GCKR rs1260326T, as expected, all SNP frequencies in the MEZ population had intermediate values between its two main ancestral populations (MAs and Iberian populations in Spain [IBS]). We detected ethnic differences in linkage disequilibrium patterns and haplotype structure between MAs and MEZs, possibly due to the high genetic heterogeneity in these populations. Remarkably, AKT1 was associated with hypertension in MEZs, but not in MAs. GCKR was associated with protection against type 2 diabetes (T2D) in MAs, and with hypertriglyceridemia and protection against low HDL Cholesterol (HDL-C) levels in MEZs. The CAT haplotype in SOCS3 was associated with metabolic syndrome (MetS) in MEZs, and correlated with protection against high blood pressure (HBP) and risk for high waist circumference and T2D in MAs. Our results show differential genetic associations with metabolic traits between MAs and MEZs, possibly due to the differences in genetic structure between these Mexican populations.
美洲印第安人血统似乎是代谢疾病(MetD)的一个风险因素,这使得墨西哥人成为更好地了解代谢健康遗传结构的理想人群。在这项研究中,我们确定了先前报道的与代谢实体相关的遗传变异在两个墨西哥人群中的关联,其中包括迄今为止报告的最大的美洲印第安人样本。我们研究了 57 个族群中 1923 名墨西哥美洲印第安人(MAs)和 855 名梅斯蒂索人(MEZs)中 8 个单核苷酸多态性(SNP)与不同代谢特征的关联。AKT1、GCKR 和 SOCS3 基因中的 7/8 个 SNP 的等位基因频率在 MAs 和 MEZs 之间存在显著差异。有趣的是,一些等位基因在特定族群中是单态的,而在其他族群中则是高度频繁的。除了 GCKR rs1260326T 外,正如预期的那样,MEZ 人群中的所有 SNP 频率都在其两个主要祖先群体(MAs 和西班牙的伊比利亚人群[IBS])之间处于中间值。我们检测到 MAs 和 MEZs 之间连锁不平衡模式和单倍型结构的族群差异,这可能是由于这些人群中的遗传高度异质性所致。值得注意的是,AKT1 与 MEZs 的高血压有关,但与 MAs 无关。GCKR 与 MAs 中的 2 型糖尿病(T2D)保护有关,与 MEZs 中的高甘油三酯血症和低高密度脂蛋白胆固醇(HDL-C)水平保护有关。SOCS3 中的 CAT 单倍型与 MEZs 中的代谢综合征(MetS)有关,并与 MAs 中的高血压保护、高腰围和 T2D 风险相关。我们的研究结果表明,MAs 和 MEZs 之间的代谢特征存在不同的遗传关联,这可能是由于这些墨西哥人群之间遗传结构的差异所致。